The initial impact of the SARS-CoV-2 pandemic on epilepsy research

Nancy Volkers; Samuel Wiebe; Ali Akbar Asadi-Pooya; Ganna Balagura; Patricia Gómez-Iglesias; Alla Guekht; Julie Hall; Akio Ikeda; Nathalie Jetté; Nirmeen A. Kishk; Peter Murphy; Emilio Perucca; Juan Carlos Pérez-Poveda; Emmanuel O. Sanya; Eugen Trinka; Dong Zhou; J. Helen Cross

doi:10.1002/epi4.12471

The initial impact of the SARS-CoV-2 pandemic on epilepsy research

Nancy Volkers, Samuel Wiebe, Ali Akbar Asadi-Pooya, Ganna Balagura, Patricia Gómez-Iglesias, Alla Guekht, Julie Hall, Akio Ikeda, Nathalie Jetté, Nirmeen A. Kishk, Peter Murphy, Emilio Perucca, Juan Carlos Pérez-Poveda, Emmanuel O. Sanya, Eugen Trinka, Dong Zhou, J. Helen Cross

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

The COVID-19 pandemic has changed the face of many practices throughout the world. Through necessity to minimize spread and provide clinical care to those with severe disease, focus has been on limiting face-to-face contact. Research in many areas has been put on hold. We sought to determine the impact of the COVID-19 pandemic on epilepsy research from international basic science and clinical researchers. Responses to five questions were solicited through a convenience sample by direct email and through postings on the ILAE social media accounts and an ILAE online platform (utilizing Slack). Information was collected from 15 respondents in 11 countries by email or via Zoom interviews between May 19, 2020, and June 4, 2020. Several themes emerged including a move to virtual working, project delays with laboratory work halted and clinical work reduced, funding concerns, a worry about false data with regard to COVID research and concern about research time lost. However, a number of positive outcomes were highlighted, not least the efficiency of online working and other adaptations that could be sustained in the future.

Original language	English
Pages (from-to)	255-265
Number of pages	11
Journal	Epilepsia Open
Volume	6
Issue number	2
DOIs	https://doi.org/10.1002/epi4.12471
State	Published - Jun 2021

Keywords

COVID-19
epilepsy care
epilepsy research
pandemic
virtual working

Access to Document

10.1002/epi4.12471

Cite this

Volkers, N., Wiebe, S., Asadi-Pooya, A. A., Balagura, G., Gómez-Iglesias, P., Guekht, A., Hall, J., Ikeda, A., Jetté, N., Kishk, N. A., Murphy, P., Perucca, E., Pérez-Poveda, J. C., Sanya, E. O., Trinka, E., Zhou, D., & Cross, J. H. (2021). The initial impact of the SARS-CoV-2 pandemic on epilepsy research. Epilepsia Open, 6(2), 255-265. https://doi.org/10.1002/epi4.12471

@article{d17d9ecb224243149f915a73c01b8adf,

title = "The initial impact of the SARS-CoV-2 pandemic on epilepsy research",

abstract = "The COVID-19 pandemic has changed the face of many practices throughout the world. Through necessity to minimize spread and provide clinical care to those with severe disease, focus has been on limiting face-to-face contact. Research in many areas has been put on hold. We sought to determine the impact of the COVID-19 pandemic on epilepsy research from international basic science and clinical researchers. Responses to five questions were solicited through a convenience sample by direct email and through postings on the ILAE social media accounts and an ILAE online platform (utilizing Slack). Information was collected from 15 respondents in 11 countries by email or via Zoom interviews between May 19, 2020, and June 4, 2020. Several themes emerged including a move to virtual working, project delays with laboratory work halted and clinical work reduced, funding concerns, a worry about false data with regard to COVID research and concern about research time lost. However, a number of positive outcomes were highlighted, not least the efficiency of online working and other adaptations that could be sustained in the future.",

keywords = "COVID-19, epilepsy care, epilepsy research, pandemic, virtual working",

author = "Nancy Volkers and Samuel Wiebe and Asadi-Pooya, {Ali Akbar} and Ganna Balagura and Patricia G{\'o}mez-Iglesias and Alla Guekht and Julie Hall and Akio Ikeda and Nathalie Jett{\'e} and Kishk, {Nirmeen A.} and Peter Murphy and Emilio Perucca and P{\'e}rez-Poveda, {Juan Carlos} and Sanya, {Emmanuel O.} and Eugen Trinka and Dong Zhou and Cross, {J. Helen}",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy",

year = "2021",

month = jun,

doi = "10.1002/epi4.12471",

language = "English",

volume = "6",

pages = "255--265",

journal = "Epilepsia Open",

issn = "2470-9239",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - The initial impact of the SARS-CoV-2 pandemic on epilepsy research

AU - Volkers, Nancy

AU - Wiebe, Samuel

AU - Asadi-Pooya, Ali Akbar

AU - Balagura, Ganna

AU - Gómez-Iglesias, Patricia

AU - Guekht, Alla

AU - Hall, Julie

AU - Ikeda, Akio

AU - Jetté, Nathalie

AU - Kishk, Nirmeen A.

AU - Murphy, Peter

AU - Perucca, Emilio

AU - Pérez-Poveda, Juan Carlos

AU - Sanya, Emmanuel O.

AU - Trinka, Eugen

AU - Zhou, Dong

AU - Cross, J. Helen

PY - 2021/6

Y1 - 2021/6

N2 - The COVID-19 pandemic has changed the face of many practices throughout the world. Through necessity to minimize spread and provide clinical care to those with severe disease, focus has been on limiting face-to-face contact. Research in many areas has been put on hold. We sought to determine the impact of the COVID-19 pandemic on epilepsy research from international basic science and clinical researchers. Responses to five questions were solicited through a convenience sample by direct email and through postings on the ILAE social media accounts and an ILAE online platform (utilizing Slack). Information was collected from 15 respondents in 11 countries by email or via Zoom interviews between May 19, 2020, and June 4, 2020. Several themes emerged including a move to virtual working, project delays with laboratory work halted and clinical work reduced, funding concerns, a worry about false data with regard to COVID research and concern about research time lost. However, a number of positive outcomes were highlighted, not least the efficiency of online working and other adaptations that could be sustained in the future.

AB - The COVID-19 pandemic has changed the face of many practices throughout the world. Through necessity to minimize spread and provide clinical care to those with severe disease, focus has been on limiting face-to-face contact. Research in many areas has been put on hold. We sought to determine the impact of the COVID-19 pandemic on epilepsy research from international basic science and clinical researchers. Responses to five questions were solicited through a convenience sample by direct email and through postings on the ILAE social media accounts and an ILAE online platform (utilizing Slack). Information was collected from 15 respondents in 11 countries by email or via Zoom interviews between May 19, 2020, and June 4, 2020. Several themes emerged including a move to virtual working, project delays with laboratory work halted and clinical work reduced, funding concerns, a worry about false data with regard to COVID research and concern about research time lost. However, a number of positive outcomes were highlighted, not least the efficiency of online working and other adaptations that could be sustained in the future.

KW - COVID-19

KW - epilepsy care

KW - epilepsy research

KW - pandemic

KW - virtual working

UR - http://www.scopus.com/inward/record.url?scp=85101630268&partnerID=8YFLogxK

U2 - 10.1002/epi4.12471

DO - 10.1002/epi4.12471

M3 - Review article

C2 - 34033250

AN - SCOPUS:85101630268

SN - 2470-9239

VL - 6

SP - 255

EP - 265

JO - Epilepsia Open

JF - Epilepsia Open

IS - 2

ER -

The initial impact of the SARS-CoV-2 pandemic on epilepsy research

Abstract

Keywords

Access to Document

Fingerprint

Cite this